Mr
Craig
Thomson

Partner & Patent Attorney

Glasgow Office Aberdeen Office Westport Office Dublin Office

Telephone. +44(0) 141 229 5800
Mobile. +44(0) 798 808 8054
Email. [email protected]

Experience

Craig is recognised for providing pragmatic, commercially focused advice to clients in the biotechnological, pharmaceutical, chemical and MedTech sectors. As well as patent drafting and prosecution, Craig advises on the development of company-wide IP strategies, funding/acquisition due-diligence, and aggressive/defensive strategies in relation to third-party IP.

Having worked closely with multi-national corporations, Craig understands the challenges associated with efficiently prosecuting large multi-national patent portfolios, whilst keeping them relevant to the business. He values this experience as it helps him to provide expert guidance to SMEs as they grow or prepare for acquisition.
Whilst part of Craig’s focus is ensuring that technical aspects of each invention is accurately captured in a patent, he understands that the value of IP can only be fully realised after understanding the commercial goals of a business, and how IP can best be exploited to help underpin those goals. It is therefore important for him to understand more generally his client’s business; enabling him to provide them with a more broad-ranging, effective and valuable set of solutions. Industry sectors for which Craig has considerable knowledge of include those concerned with the microbiome, food, formulations, anti-infectives, diagnostics and MedTech.

Craig has a proven track record of providing successful outcomes for clients, both in a wide-range of legal proceedings (including opposition, entitlement, and USPTO interviews) and in successful IP-license/assignment deals involving patents that he both drafted and prosecuted to grant. He has co-written an amicus curiae (filed with the US Supreme Court for Sequenom v Ariosa), and has assisted many clients to successfully obtain investment, including listing on AIM.

Specialisms

  • Anti infectives
  • Bioprocessing
  • Diagnostics
  • Food technology
  • Gene editing technologies
  • Immunobiology
  • Microbiome
  • Personalised medicine

Industries

  • Food & drink icon Food & drink
  • Healthcare icon Healthcare
  • Medical devices icon Medical devices
  • Pharmaceuticals icon Pharmaceuticals

Services

  • Due diligence
  • Patent oppositions & appeals
  • Patents
  • Portfolio management
  • Searching & competitor monitoring
  • Strategy

Qualifications

Patent Attorney

Chartered (UK)
European
Irish


BSC

Physiology and Pharmacology

MSC

Management of Intellectual Property

Recognition

IAM Patent 1000: The World’s Leading Patent Professionals 2020

“Craig Thomson, who is well versed in all things biotechnological and pharmaceutical, particularly therapeutic and diagnostic inventions. He has a “phenomenal ability to quickly grasp the key concepts in an invention and tease out the most inventive aspects so as to file the strongest possible patents. He is always on hand to guide patent strategy and has incredible patience when explaining the intricacies of the prosecution process. He is also ridiculously good fun to work with!” “He takes a practical, business-oriented approach, focusing on what will drive value in the European market in a way that enables informed decision making. In view of technological convergence, his technical versatility is invaluable.””

View recognition online

IAM Patent 1000: The World’s Leading Patent Professionals 2019

“Taking the reins on this initiative is Craig Thomson, an experienced handler of biotech, pharmaceutical, chemical and medical innovations. Thomson is a seasoned prosecutor and serves up trenchant advice on IP strategy in connection with technology-driven deals and enforcement issues; the broad ambit of his practice has helped him develop a refined commercial sense.”

Publications

KTN Microbiome Strategic Roadmap

View publication online

IAM Patent 1000 2020

View publication online

The Vedanta Opposition: A healthy sign of a maturing industry

View publication online

IAM Patent 1000 2019

View publication online

The Vedanta Opposition: A healthy sign of a maturing industry

View publication online

Download publication PDF

Securing Commercial Advantage Through Innovations in Microbiome Therapeutic Production

View publication online

Download publication PDF

Validity Attack on US Patent for Bifidobacetrium ComboTherapy: What can we learn?

View publication online

Download publication PDF

LSIPR: Will Big Pharma Get The Bug For Microbiome Therapies?

View publication online

Conferences: 2021

March 24th 2021

Animal Microbiome Conference 2021

Speaker

March 3rd 2021

Animal Microbiome Congress 2021

Speaker

Event details

January 27th 2021

IAM webinar: Preparing for the IP due diligence checklist of the future for microbiome innovation

Speaker

Event details

January 14th 2021

HGF IP in Healthcare Virtual Conference 2021

Speaker

Event details

Conferences: 2020

October 15th 2020

4th Microbiome: Recent Developments, Regulatory, Quality and Commercialization Summit

Speaker

Event details

October 15th 2020

Microbiome Movement - Maternal & Infant Health Summit 2020

Speaker

Event details

September 8th 2020

Sustainable Protein Production and Animal Microbiome Virtual Summit 2020

Speaker

Event details

September 1st 2020

ONE Life Sciences Leadership Forum 6

Speaker

Event details

July 8th 2020

Webinar: Attracting big pharma to the Microbiome field

Speaker

Event details

April 24th 2020

Translational Microbiome Conference 2020

Speaker

Event details

Conferences: 2019

September 26th 2019

Medical Technology Ireland - Galway Racecourse

Speaker

Event details

June 3rd 2019

2019 BIO International Convention - Philadelphia

Attended

Event details

CSR

Craig provides the annual lecture, “Capturing, Protecting and Exploiting Intellectual Property in Business”, on the Masters Course for “Management of Innovation and Creativity” at Glasgow Caledonian University.

As IP lead, Craig is part of the Microbiome Innovation Network, part of the KTN, whos aims are to accelerate the commercialisation of microbiome-based products and services in the UK and create a vibrant community by connecting industry and academia. Craig also wrote the IP section for the Networks Roadmap document for the industry (https://ktn-uk.org/agrifood/microbiome/).

Related News

Managing Intellectual Property IP Stars & Firm Rankings 2021

Managing Intellectual Property IP Stars 2021, comprising the highly recommended IP professionals, has now been published. HGF is delighted to have 14 European attorneys listed. IP STARS is the leading …

Read article

Medical technology most patented subject matter at EPO in 2020

Pharmaceutical and biotechnology patent applications also make top 10 most patented. Recent statistics published by the EPO show that a total of 14,295 European patent applications were filed in 2020 …

Read article

The EPO ‘How To’ guide for antibody applications in Europe

The 2021 EPO Guidelines provide much needed guidance on how to protect antibodies in Europe. Biological drugs including therapeutic antibodies have become increasingly important to the pharmaceutical industry. The European …

Read article

Personalised drug patenting in Europe

Opportunities for additional pharmaceutical product patent protection in Europe, based on the use of a drug to treat a patient exhibiting a biomarker indicative of drug response. Recent years have …

Read article

The Internet of Medical Things

Exploring the growth of patents for connected medical devices, and how best to protect them. The Internet of Things (IoT) is expected to change our lives by creating a connected …

Read article

Covid-19 vaccine patent waivers

To waive, or not to waive, that is the question. The earliest identified date of a patient presenting with symptoms of a “novel coronavirus” in Wuhan, China is reported to …

Read article

G1/21 hearing at the EPO

Follow this page for the updates from G1/21 hearing at the EPO on 28th May 2021. HGF Partners Dr Chris Moore and Douglas Drysdale will be reporting all the key …

Read article
Event - 9th June 2021

Webinar: Developing effective patent strategies for personalised medical devices in Europe and the US

HGF in Europe and Knobbe Martens in the US are holding a joint webinar on 9th June. In this webinar we will explore considerations for implementing an effective strategy to …

Event details

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.